昭衍新药 (06127.HK)

+ 收藏

利润表(昭衍新药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2026年中报2026年一季报2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
起始日期 2026-01-012026-01-012025-01-012025-01-012025-01-012025-01-012024-01-012024-01-012024-01-012024-01-01
截止日期 2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231123112311231
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后上市后上市后
原始币种 人民币人民币人民币人民币人民币人民币人民币人民币人民币人民币
营业收入计算(元) 会员可见会员可见会员可见会员可见668,575,000.00287,337,235.012,018,334,000.001,335,156,050.40849,357,000.00324,809,103.67
销售成本(元) 会员可见会员可见会员可见会员可见-563,580,000.00-205,132,917.71-1,512,794,000.00-968,251,629.50-638,056,000.00-218,156,989.73
毛利计算(元) 会员可见会员可见会员可见会员可见104,995,000.0082,204,317.30505,540,000.00366,904,420.90211,301,000.00106,652,113.94
其他收入(元) 会员可见会员可见会员可见会员可见82,919,000.006,554,664.62161,181,000.0050,840,756.7180,124,000.0013,633,321.77
销售及分销成本(元) 会员可见会员可见会员可见会员可见-14,609,000.00-6,079,268.59-27,881,000.00-19,402,507.49-12,163,000.00-5,850,463.87
行政开支(元) 会员可见会员可见会员可见会员可见-143,941,000.00-71,784,152.89-315,934,000.00-236,735,760.07-168,555,000.00-71,961,656.69
研发费用(元) 会员可见会员可见会员可见会员可见-43,446,000.00-23,027,883.99-92,918,000.00-71,085,657.06-47,840,000.00-22,967,298.39
其他支出(元) -会员可见-会员可见--47,246.62--327,422.81--132,105.74
资产减值损失(元) -会员可见-会员可见--22,083,521.16--36,957,279.54--28,132,768.27
重估盈余(元) 会员可见会员可见会员可见会员可见94,977,000.0065,875,504.16-122,942,000.00-190,401,449.68-254,441,000.00-310,012,920.11
出售资产之溢利(元) -会员可见-会员可见----468,673.84--
经营溢利计算(元) 会员可见会员可见会员可见会员可见80,895,000.0031,612,412.83107,046,000.00-137,633,572.88-191,574,000.00-318,771,777.36
应占联营公司溢利(元) -------559,000.00-15,472,000.00-
财务成本(元) 会员可见会员可见会员可见会员可见-776,000.0019,123,449.11-2,448,000.0074,635,915.74-1,249,000.0028,011,483.04
影响税前利润的其他项目(元) -会员可见-会员可见--1,352,112.14--6,894,612.65--2,369,721.32
税前利润(元) 会员可见会员可见会员可见会员可见80,119,000.0049,383,749.80104,039,000.00-69,892,269.79-177,351,000.00-293,130,015.64
所得税(元) 会员可见会员可见会员可见会员可见-19,187,000.00-8,264,284.55-34,284,000.00-4,351,740.155,113,000.0019,766,412.57
净利润(元) 会员可见会员可见会员可见会员可见60,932,000.0041,119,465.2569,755,000.00-74,244,009.94-172,238,000.00-273,363,603.07
 本公司拥有人应占净利润(元) 会员可见会员可见会员可见会员可见60,932,000.0041,119,492.2374,075,000.00-70,307,075.11-169,742,000.00-272,222,474.99
 非控股权益应占净利润(元) 会员可见会员可见会员可见会员可见--26.98-4,320,000.00-3,936,934.83-2,496,000.00-1,141,128.08
每股收益
 基本每股收益(元) 会员可见会员可见会员可见会员可见0.080.050.10-0.09-0.23-0.36
 稀释每股收益(元) 会员可见会员可见会员可见会员可见0.080.050.10-0.09-0.23-0.36
其他全面收益(元) 会员可见会员可见会员可见会员可见-2,334,000.00-766,939.36-51,041,000.00-4,859,185.753,025,000.00863,793.54
全面收益总额(元) 会员可见会员可见会员可见会员可见58,598,000.0040,352,525.8918,714,000.00-79,103,195.69-169,213,000.00-272,499,809.53
 本公司拥有人应占全面收益总额(元) 会员可见会员可见会员可见会员可见58,598,000.0040,352,552.8723,034,000.00-75,166,260.86-166,717,000.00-271,358,681.45
 非控股权益应占全面收益总额(元) 会员可见会员可见会员可见会员可见--26.98-4,320,000.00-3,936,934.83-2,496,000.00-1,141,128.08
公告日期 2026-08-282026-04-292026-04-292025-10-302025-09-292025-04-282025-04-292024-10-302024-09-272024-04-29
会计准则 国际会计准则大陆会计准则国际会计准则大陆会计准则国际会计准则大陆会计准则国际会计准则大陆会计准则国际会计准则大陆会计准则
审计意见 ----------
核数师 ----------
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院